<document id="DDI-DrugBank.d380">
    <sentence id="DDI-DrugBank.d380.s0" text="Buprenorphine is metabolized to norbuprenorphine by cytochrome CYP 3A4.">
        <entity charOffset="0-12" id="DDI-DrugBank.d380.s0.e0" text="Buprenorphine" type="drug" />
        <entity charOffset="32-47" id="DDI-DrugBank.d380.s0.e1" text="norbuprenorphine" type="drug_n" />
        <pair ddi="false" e1="DDI-DrugBank.d380.s0.e0" e2="DDI-DrugBank.d380.s0.e1" id="DDI-DrugBank.d380.s0.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d380.s1" text="Because CYP 3A4 inhibitors may increase plasma concentrations of buprenorphine, patients already on CYP 3A4 inhibitors such as azole antifungals (e.g.">
        <entity charOffset="65-77" id="DDI-DrugBank.d380.s1.e0" text="buprenorphine" type="drug" />
        <entity charOffset="127-143" id="DDI-DrugBank.d380.s1.e1" text="azole antifungals" type="group" />
        <pair ddi="false" e1="DDI-DrugBank.d380.s1.e0" e2="DDI-DrugBank.d380.s1.e1" id="DDI-DrugBank.d380.s1.p0" />
    </sentence>
    <sentence id="DDI-DrugBank.d380.s5" text="In many of these cases, buprenorphine was misused by self-injection of crushed SUBUTEX tablets.">
        <entity charOffset="24-36" id="DDI-DrugBank.d380.s5.e0" text="buprenorphine" type="drug" />
        <entity charOffset="79-85" id="DDI-DrugBank.d380.s5.e1" text="SUBUTEX" type="brand" />
        <pair ddi="false" e1="DDI-DrugBank.d380.s5.e0" e2="DDI-DrugBank.d380.s5.e1" id="DDI-DrugBank.d380.s5.p0" />
    </sentence>
    </document>